25.305 USD
-0.57 (-2.18%)
Taking everything into account, IMNM scores 3 out of 10 in our fundamental rating. IMNM was compared to 525 industry peers in the Biotechnology industry. IMNM has a great financial health rating, but its profitability evaluates not so good. IMNM has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- IMNM had negative earnings in the past year.
- In the past year IMNM has reported a negative cash flow from operations.
- In the past 5 years IMNM always reported negative net income.
- IMNM had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of IMNM (-74.40%) is worse than 64.57% of its industry peers.
- IMNM has a Return On Equity (-84.40%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -74.4% | ||
| ROE | -84.4% | ||
| ROIC | N/A |
ROA(3y)-116.62%
ROA(5y)-86.52%
ROE(3y)-158.72%
ROE(5y)-114.11%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- IMNM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- IMNM does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, IMNM has more shares outstanding
- Compared to 5 years ago, IMNM has more shares outstanding
- There is no outstanding debt for IMNM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 35.82 indicates that IMNM is not in any danger for bankruptcy at the moment.
- IMNM has a better Altman-Z score (35.82) than 94.10% of its industry peers.
- There is no outstanding debt for IMNM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 35.82 |
ROIC/WACCN/A
WACC8.88%
2.3 Liquidity
- A Current Ratio of 8.90 indicates that IMNM has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 8.90, IMNM is in the better half of the industry, outperforming 78.29% of the companies in the same industry.
- IMNM has a Quick Ratio of 8.90. This indicates that IMNM is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of IMNM (8.90) is better than 78.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.9 | ||
| Quick Ratio | 8.9 |
3. Growth
3.1 Past
- IMNM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.63%, which is quite impressive.
- Looking at the last year, IMNM shows a decrease in Revenue. The Revenue has decreased by -4.44% in the last year.
EPS 1Y (TTM)63.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
Revenue 1Y (TTM)-4.44%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
3.2 Future
- The Earnings Per Share is expected to grow by 15.62% on average over the next years. This is quite good.
- The Revenue is expected to grow by 106.11% on average over the next years. This is a very strong growth
EPS Next Y55.17%
EPS Next 2Y21.76%
EPS Next 3Y15.82%
EPS Next 5Y15.62%
Revenue Next Year-23.19%
Revenue Next 2Y-7.45%
Revenue Next 3Y104.57%
Revenue Next 5Y106.11%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- IMNM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IMNM. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- IMNM's earnings are expected to grow with 15.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.76%
EPS Next 3Y15.82%
5. Dividend
5.1 Amount
- No dividends for IMNM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
IMMUNOME INC / IMNM FAQ
What is the ChartMill fundamental rating of IMMUNOME INC (IMNM) stock?
ChartMill assigns a fundamental rating of 3 / 10 to IMNM.
What is the valuation status of IMMUNOME INC (IMNM) stock?
ChartMill assigns a valuation rating of 0 / 10 to IMMUNOME INC (IMNM). This can be considered as Overvalued.
What is the profitability of IMNM stock?
IMMUNOME INC (IMNM) has a profitability rating of 0 / 10.
What is the financial health of IMMUNOME INC (IMNM) stock?
The financial health rating of IMMUNOME INC (IMNM) is 8 / 10.